|
⚲
|
| Keyboard |
| Quan Venture Fund II LP
✚
|
|
|---|---|
| CIK # | 0001750370 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001750370] | |
| 4 | [0001750370] | |
| D | [0001750370] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Design Therapeutics Inc | |
| Quan Venture Fund II LP | |
| Xu Stella | |
| NextCure Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Design Therapeutics Inc DSGN
Common Stock
|
2021-03-30 | Conversion | 4,439,839 | ||
|
Design Therapeutics Inc DSGN
Common Stock
|
2021-03-30 | Conversion | 280,991 | ||
|
Design Therapeutics Inc DSGN
Series B Preferred Stock · derivative
|
2021-03-30 | Conversion | 458,016 | ||
|
Design Therapeutics Inc DSGN
Series A Preferred Stock · derivative
|
2021-03-30 | Conversion | 7,236,938 |